• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,200.68 -893.39
( -1.16%)
Global Indices
Nasdaq
51,748.06 162.36
(0.31%)
Dow Jones
7,496.17 -25.41
(-0.34%)
Hang Seng
70,132.76 -2,221.20
(-3.07%)
Nikkei 225
10,441.93 78.66
(0.76%)
Forex
USD-INR
94.32 -0.07
(-0.07%)
EUR-INR
108.15 -0.25
(-0.23%)
GBP-INR
124.70 -0.38
(-0.31%)
JPY-INR
0.58 0.00
(-0.32%)

EQUITY - MARKET SCREENER

Marksans Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524404
INE750C01026
36.4615746
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MARKSANS
38.57
11605.52
EPS(TTM)
Face Value()
Div & Yield %
6.64
1
0.35
 

Route Mobile consolidated net profit rises 93.21% in the March 2026 quarter
May 08,2026
Net profit of Route Mobile rose 93.21% to Rs 109.32 crore in the quarter ended March 2026 as against Rs 56.58 crore during the previous quarter ended March 2025. Sales declined 3.75% to Rs 1130.90 crore in the quarter ended March 2026 as against Rs 1175.00 crore during the previous quarter ended March 2025.

For the full year,net profit declined 25.04% to Rs 239.02 crore in the year ended March 2026 as against Rs 318.85 crore during the previous year ended March 2025. Sales declined 3.66% to Rs 4408.21 crore in the year ended March 2026 as against Rs 4575.62 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1130.901175.00 -4 4408.214575.62 -4
OPM %12.0510.37 -12.1911.53 -
PBDT162.88125.90 29 580.52533.64 9
PBT139.27103.68 34 488.91444.56 10
NP109.3256.58 93 239.02318.85 -25